You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sorafenib

Showing 26 - 50 of 1,094
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Hepatocellular Trial in Loma Linda (Proton Beam Radiotherapy, Sorafenib)

Terminated
Has Results
  • Carcinoma, Hepatocellular
  • Proton Beam Radiotherapy
  • Sorafenib
  • Loma Linda, California
    Loma Linda University Medical Center
Sep 21, 2021

Differentiated Thyroid Cancer Trial in Philadelphia (Everolimus, Sorafenib)

Active, not recruiting
  • Differentiated Thyroid Cancer
  • Philadelphia, Pennsylvania
    Hospital of the University of Pennsylvania
Oct 18, 2021

HepatoCellular Carcinoma, Portal Vein Thrombosis Trial in Beijing (HAIC, Sorafenib)

Completed
  • HepatoCellular Carcinoma
  • Portal Vein Thrombosis
  • HAIC
  • Sorafenib
  • Beijing, Beijing, China
    Peking University Cancer Hospital
Oct 8, 2021

Hepatocellular Carcinoma Trial in Barcelona, Madrid, Oviedo (Cabozantinib)

Active, not recruiting
  • Hepatocellular Carcinoma
  • Barcelona, Spain
  • +5 more
Jul 7, 2022

Breast Cancer, Brain Metastases Trial in United States (Whole Brain Radiotherapy (WBRT), Sorafenib)

Completed
  • Breast Cancer
  • Brain Metastases
  • Whole Brain Radiotherapy (WBRT)
  • Sorafenib
  • Basking Ridge, New Jersey
  • +5 more
Mar 4, 2022

Glioblastoma, Recurrent Adult Brain Tumor, Malignant Glioma Trial in Richmond (sorafenib tosylate, valproic acid, sildenafil

Active, not recruiting
Has Results
  • Glioblastoma
  • +3 more
  • sorafenib tosylate
  • +2 more
  • Richmond, Virginia
    Virginia Commonwealth University/Massey Cancer Center
Mar 21, 2022

Hepatocellular Carcinoma, Hepatoma Trial in Baltimore (sorafenib, LC Bead-TACE)

Completed
Has Results
  • Hepatocellular Carcinoma
  • Hepatoma
  • sorafenib
  • LC Bead-TACE
  • Baltimore, Maryland
    The Johns Hopkins Hospital
Oct 15, 2021

Advanced Adult Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Recurrent Adult Hepatocellular Carcinoma Trial

Completed
Has Results
  • Advanced Adult Hepatocellular Carcinoma
  • +10 more
  • Laboratory Biomarker Analysis
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 1, 2021

Co-existing Mutations on Sorafenib Maintenance Therapy After

Completed
  • Acute Myeloid Leukemia
  • +2 more
  • Sorafenib
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
May 30, 2022

Pleomorphic Rhabdomyosarcoma, Stage IIB Adult Soft Tissue Sarcoma AJCC v7, Stage III Adult Soft Tissue Sarcoma AJCC v7 Trial in

Completed
Has Results
  • Pleomorphic Rhabdomyosarcoma
  • +3 more
  • Epirubicin Hydrochloride
  • +5 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Feb 23, 2022

Hepatocellular Carcinoma Trial in Xi'an (Recombinant Human Adenovirus Type 5 injection, Sorafenib)

Active, not recruiting
  • Hepatocellular Carcinoma
  • Recombinant Human Adenovirus Type 5 injection
  • Sorafenib
  • Xi'an, Shaanxi, China
  • +3 more
Jan 25, 2022

Hepatocellular Carcinoma Trial in Guangzhou (HAIC, Sorafenib)

Completed
  • Hepatocellular Carcinoma
  • HAIC
  • Sorafenib
  • Guangzhou, Guangdong, China
    Cancer Center Sun Yat-sen University
Nov 16, 2021

Hepatocellular Carcinoma Trial in Toronto (Sorafenib)

Completed
  • Hepatocellular Carcinoma
  • Sorafenib
  • Toronto, Ontario, Canada
    University Health Network
Oct 4, 2021

Pancreas Cancer Trial in Scottsdale (Vemurafenib, Sorafenib)

Recruiting
  • Pancreas Cancer
  • Scottsdale, Arizona
    HonorHealth Research Institute
Oct 28, 2021

HCC Trial in Hong Kong (Zabadinostat (CXD101) and Geptanolimab, Lenvatinib and Sorafenib)

Not yet recruiting
  • HCC
  • Zabadinostat (CXD101) and Geptanolimab
  • Lenvatinib and Sorafenib
  • Hong Kong, Hong Kong
    Department of Clinical Oncology, Prince of Wales Hospital
May 15, 2023

Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Squamous Cell Carcinoma of the Hypopharynx, Metastatic Squamous

Active, not recruiting
  • Metastatic Head and Neck Squamous Cell Carcinoma
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 27, 2022

Hepatocellular Carcinoma Trial in Pavia (TAC-101, Placebo)

Terminated
Has Results
  • Hepatocellular Carcinoma
  • Pavia, Italy
    I.R.C.C.S. San Matteo University Hospital, Golgi
Jan 3, 2022

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (procedure, drug, biological)

Recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Hepatocellular Carcinoma, Radiotherapy, Sorafenib Trial in Beijing (concurrent sorafenib and IMRT, followed sorafenib

Completed
  • Hepatocellular Carcinoma, Radiotherapy, Sorafenib
  • concurrent sorafenib and IMRT, followed sorafenib maintenance
  • Beijing, Beijing, China
    Bo Chen
Jun 16, 2021

Adult Primary Hepatocellular Carcinoma, Localized Resectable Adult Primary Liver Cancer, Localized Unresectable Adult Primary

Suspended
  • Adult Primary Hepatocellular Carcinoma
  • +3 more
  • sorafenib tosylate
  • +2 more
  • Birmingham, Alabama
  • +20 more
Aug 29, 2022

Acute Leukemia, Relapse, Hematopoietic Stem Cell Transplantation Trial in Guangzhou (Sorafenib)

Recruiting
  • Acute Leukemia
  • +2 more
  • Sorafenib
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Oct 30, 2021

BCLC Stage C Hepatocellular Carcinoma Trial in Hangzhou (TACE, Tilelizumab, Sorafenib)

Not yet recruiting
  • BCLC Stage C Hepatocellular Carcinoma
  • TACE
  • +2 more
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, College of Medicine, Zhejiang Uni
Aug 10, 2021

Hepatocellular Carcinoma Trial in United States (BBI608, BBI503, Sorafenib)

Completed
Has Results
  • Hepatocellular Carcinoma
  • Gilbert, Arizona
  • +28 more
Apr 4, 2022

Hepatocarcinoma Trial in France (Intplex test)

Active, not recruiting
  • Hepatocarcinoma
  • Intplex test
  • Montpellier, Hérault, France
  • +5 more
Jan 25, 2022

Carcinoma, Hepatocellular Trial in Darmstadt (Tepotinib)

Completed
Has Results
  • Carcinoma, Hepatocellular
  • Darmstadt, Germany
    Please contact the Merck KGaA Communication Center located in
Aug 22, 2022